Global MicroRNA Profiling of the Mouse Ventricles during Development of Severe Hypertrophic Cardiomyopathy and Heart Failure

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Bagnall, Richard D ^a,b   Tsoutsman, Tatiana ^a,b   Shephard, Rhian E ^a,b   Ritchie, William ^c   Semsarian, Christopher ^a,b,c  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 16; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DOWN REGULATION; ELECTROPHYSIOLOGY; EXTRACELLULAR MATRIX; FIBROSIS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC RISK; HEART FAILURE; HEART VENTRICLE; HYPERTROPHIC CARDIOMYOPATHY; MOUSE; NONHUMAN; PATHOGENESIS; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; TIME; UPREGULATION;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART FAILURE; HEART VENTRICLES; MALE; MICE; MICE, TRANSGENIC; MICRORNAS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

MUS MUSCULUS;

EID: 84866430390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044744     Document Type: Article

References (42)

1. Kozomara A, Griffiths-Jones S, (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-157.
2. Small EM, Frost RJ, Olson EN, (2010) MicroRNAs add a new dimension to cardiovascular disease. Circulation 121: 1022-1032.
3. Berezikov E, Chung WJ, Willis J, Cuppen E, Lai EC, (2007) Mammalian mirtron genes. Mol Cell 28: 328-336.
4. Bartel DP, (2009) MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233.
5. Catalucci D, Gallo P, Condorelli G, (2009) MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet 2: 402-408.
6. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, et al. (2006) A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 103: 18255-18260.
7. Cheng Y, Ji R, Yue J, Yang J, Liu X, et al. (2007) MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170: 1831-1840.
8. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M, (2007) MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
9. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, et al. (2007) Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42: 1137-1141.
10. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, et al. (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105: 13027-13032.
11. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, et al. (2007) Altered microRNA expression in human heart disease. Physiol Genomics 31: 367-373.
12. Sucharov C, Bristow MR, Port JD, (2008) miRNA expression in the failing human heart: functional correlates. J Mol Cell Cardiol 45: 185-192.
13. Lind JM, Chiu C, Semsarian C, (2006) Genetic basis of hypertrophic cardiomyopathy. Expert review of cardiovascular therapy 4: 927-934.
14. Seidman JG, Seidman C, (2001) The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104: 557-567.
15. Ingles J, Doolan A, Chiu C, Seidman J, Seidman C, et al. (2005) Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 42: e59.
16. Maron BJ, Maron MS, Semsarian C, (2012) Double or compound sarcomere mutations in hypertrophic cardiomyopathy: A potential link to sudden death in the absence of conventional risk factors. Heart rhythm: the official journal of the Heart Rhythm Society 9: 57-63.
17. Tsoutsman T, Bagnall RD, Semsarian C, (2008) Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure. Clin Exp Pharmacol Physiol 35: 1349-1357.
18. Van Driest SL, Vasile VC, Ommen SR, Will ML, Tajik AJ, et al. (2004) Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 1903-1910.
19. Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, et al. (2008) Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 358: 1899-1908.
20. Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, et al. (2008) Severe heart failure and early mortality in a double-mutation mouse model of familial hypertrophic cardiomyopathy. Circulation 117: 1820-1831.
21. Shephard R, Semsarian C, (2009) Role of animal models in HCM research. J Cardiovasc Transl Res 2: 471-482.
22. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
23. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
24. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
25. Ikeda S, He A, Kong SW, Lu J, Bejar R, et al. (2009) MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol Cell Biol 29: 2193-2204.
26. Zhao Y, Samal E, Srivastava D, (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-220.
27. Zhao Y, Ransom JF, Li A, Vedantham V, von Drehle M, et al. (2007) Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129: 303-317.
28. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, et al. (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579.
29. Carrillo ED, Escobar Y, Gonzalez G, Hernandez A, Galindo JM, et al. (2011) Posttranscriptional regulation of the beta2-subunit of cardiac L-type Ca2+ channels by MicroRNAs during long-term exposure to isoproterenol in rats. J Cardiovasc Pharmacol 58: 470-478.
30. Duisters RF, Tijsen AJ, Schroen B, Leenders JJ, Lentink V, et al. (2009) miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res 104: 170-178, 176p following 178.
31. Sarkar S, Leaman DW, Gupta S, Sil P, Young D, et al. (2004) Cardiac overexpression of myotrophin triggers myocardial hypertrophy and heart failure in transgenic mice. J Biol Chem 279: 20422-20434.
32. Schellings MW, van Almen GC, Sage EH, Heymans S, (2009) Thrombospondins in the heart: potential functions in cardiac remodeling. J Cell Commun Signal 3: 201-213.
33. Wang B, Howel P, Bruheim S, Ju J, Owen LB, et al. (2011) Systematic evaluation of three microRNA profiling platforms: microarray, beads array, and quantitative real-time PCR array. PLoS One 6: e17167.
34. Baskerville S, Bartel DP, (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11: 241-247.
35. Lee JH, Gao C, Peng G, Greer C, Ren S, et al. (2011) Analysis of transcriptome complexity through RNA sequencing in normal and failing murine hearts. Circ Res 109: 1332-1341.
36. Matkovich SJ, Van Booven DJ, Eschenbacher WH, Dorn GW 2nd (2011) RISC RNA sequencing for context-specific identification of in vivo microRNA targets. Circ Res 108: 18-26.
37. Matkovich SJ, Zhang Y, Van Booven DJ, Dorn GW 2nd (2010) Deep mRNA sequencing for in vivo functional analysis of cardiac transcriptional regulators: application to Galphaq. Circ Res 106: 1459-1467.
38. Song HK, Hong SE, Kim T, Kim do H, (2012) Deep RNA sequencing reveals novel cardiac transcriptomic signatures for physiological and pathological hypertrophy. PLoS One 7: e35552.
39. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, et al. (2008) microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 22: 3242-3254.
40. Sarkar J, Gou D, Turaka P, Viktorova E, Ramchandran R, et al. (2010) MicroRNA-21 plays a role in hypoxia-mediated pulmonary artery smooth muscle cell proliferation and migration. Am J Physiol Lung Cell Mol Physiol 299: L861-871.
41. Jazdzewski K, Boguslawska J, Jendrzejewski J, Liyanarachchi S, Pachucki J, et al. (2011) Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC). J Clin Endocrinol Metab 96: E546-553.
42. Li Q, Song XW, Zou J, Wang GK, Kremneva E, et al. (2010) Attenuation of microRNA-1 derepresses the cytoskeleton regulatory protein twinfilin-1 to provoke cardiac hypertrophy. J Cell Sci 123: 2444-2452.